ArticleClinical, cosmetic and investigational dermatology2026
Diverging Global Patterns and Temporal Trends in Inflammatory and Infectious Skin Diseases.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Skin and subcutaneous diseases were the third most common global condition and the eighth leading cause of non-fatal health burden in 2021. Despite their high prevalence and substantial impact on quality of life, they remain relatively underprioritized in public health policy. This study aimed to examine long-term global trends and regional disparities in the burden of inflammatory and infectious skin diseases from 1990 to 2021. Patients and Methods: We conducted a cross-sectional analysis using data from the Global Burden of Disease (GBD) Study 2021. Age-standardized incidence rates, years lived with disability (YLDs), and average annual percentage change (AAPC) were assessed across 204 countries and territories, 21 global regions, and all age groups. Results: In 2021, skin and subcutaneous diseases ranked as the eighth leading cause of YLDs worldwide. Between 1990 and 2021, inflammatory skin diseases demonstrated a modest increase in incidence (AAPC 0.08%) and YLDs (0.04%). Infectious skin diseases showed a slightly greater rise in incidence (0.19%), whereas YLDs declined marginally (-0.01%). The burden varied markedly by sociodemographic index (SDI) level and age, with the greatest impact observed among individuals younger than 20 years. Conclusion: Inflammatory and infectious skin diseases exhibit distinct global trajectories and disproportionate burdens across regions and age groups. These findings highlight the importance of context-specific prevention strategies, improved equity in health service delivery, and greater policy prioritization of skin disease management in global and national health agendas.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.